Related Experiment Video
Updated: May 14, 2026
03:23
Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Eosinophils as diagnostic tools in chronic lung disease
Osama Eltboli1, Christopher E Brightling
1Department of Infection, Inflammation and Immunity, Institute of Lung Health, University of Leicester, Leicester, LE3 9QP, UK.
Expert Review of Respiratory Medicine
|February 1, 2013
Summary
Eosinophilic inflammation plays a key role in chronic respiratory diseases like asthma and COPD. Targeting eosinophils with corticosteroids can improve treatment outcomes and reduce exacerbations in these conditions.
Area of Science:
- Pulmonology
- Immunology
Background:
- Chronic lung diseases, including asthma, COPD, chronic cough, and idiopathic pulmonary fibrosis, are prevalent and pose significant health risks.
- Eosinophilic airway inflammation is a hallmark of asthma and is increasingly recognized in other chronic respiratory conditions.
Purpose of the Study:
- To review the diagnostic and therapeutic implications of eosinophilic inflammation in chronic respiratory diseases.
- To highlight the role of eosinophils in disease pathogenesis and treatment response.
Main Methods:
- Literature review of studies investigating eosinophilic inflammation in chronic lung diseases.
- Analysis of the association between sputum eosinophilia and corticosteroid treatment response.
- Evaluation of management strategies targeting sputum eosinophil counts.
Main Results:
- Sputum eosinophilia is linked to a positive response to corticosteroid therapy in asthma and COPD.
- Tailored treatment approaches focusing on normalizing sputum eosinophils have been shown to decrease exacerbation frequency.
- Eosinophilic inflammation is a relevant factor across various chronic respiratory conditions.
Conclusions:
- Eosinophilic inflammation is a critical factor in the management of several chronic respiratory diseases.
- Monitoring and targeting eosinophils can personalize treatment strategies and improve patient outcomes.
- Further research into eosinophil-driven mechanisms may lead to novel therapeutic interventions.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: